Tripla negatív emlőrák: vizsgálatok itt: Ausztria
4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleSacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- Where
- Innsbruck, Linz, Salzburg, Vienna, Wels
- Életkor
- 18 év and over
- People
- 1530 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06393374 · EU 2023-504962-52-00 - 2. fázisTaking peopleHER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011
- Where
- Innsbruck
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Abscint NV/SA
See details and how to joinNCT06369831 · EU 2024-511419-22-00 - 2/3. fázisTaking peopleA Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- Where
- Graz, Innsbruck, Salzburg, St. Poelten, Vienna
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06926868 · EU 2024-519871-24-00 - 2. fázisTaking peoplePhase II Study of daTopotamab-derUXtecan (Dato-DXd; DS-1026a) in triple-negative brEast cancer patients with newly Diagnosed or prOgressing brain metastases
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 26 worldwide
- Run by
- Medical University Of Vienna
See details and how to join2024-518819-19-00 · EU 2024-518819-19-00